Arclin Enters into Definitive Agreement to Acquire Aramids Business, including Kevlar庐 and Nomex庐 Brands, from DuPont鈩�
Arclin has entered into a definitive agreement to acquire DuPont's (NYSE:DD) Aramids business, including the iconic Kevlar庐 and Nomex庐 brands, for $1.8 billion. The transaction, expected to close in Q1 2026, will significantly expand Arclin's portfolio into aerospace, electrical infrastructure, electric vehicles, personal protection, and defense sectors.
The acquisition includes approximately 1,900 employees and will strengthen Arclin's global market presence. The deal will combine Arclin's existing expertise in construction and infrastructure with Kevlar庐 and Nomex庐's proven protective technologies, creating opportunities for innovation and market expansion.
Arclin ha siglato un accordo definitivo per acquisire il business Aramidi di DuPont (NYSE:DD), comprensivo dei rinomati marchi Kevlar庐 e Nomex庐, per 1,8 miliardi di dollari. L'operazione, il cui completamento 猫 previsto nel primo trimestre del 2026, allargher脿 significativamente il portafoglio di Arclin nei settori aerospaziale, infrastrutture elettriche, veicoli elettrici, protezione personale e difesa.
L'acquisizione include circa 1.900 dipendenti e rafforzer脿 la presenza globale di Arclin. L'unione tra l'esperienza di Arclin in costruzioni e infrastrutture e le tecnologie protettive consolidate di Kevlar庐 e Nomex庐 creer脿 nuove opportunit脿 per innovazione ed espansione sul mercato.
Arclin ha firmado un acuerdo definitivo para adquirir el negocio de aramidas de DuPont (NYSE:DD), que incluye las ic贸nicas marcas Kevlar庐 y Nomex庐, por 1.800 millones de d贸lares. La transacci贸n, que se espera cierre en el primer trimestre de 2026, ampliar谩 de forma significativa la cartera de Arclin en los sectores aeroespacial, infraestructura el茅ctrica, veh铆culos el茅ctricos, protecci贸n personal y defensa.
La adquisici贸n incluye aproximadamente 1.900 empleados y fortalecer谩 la presencia global de Arclin. La combinaci贸n de la experiencia de Arclin en construcci贸n e infraestructuras con las probadas tecnolog铆as de protecci贸n de Kevlar庐 y Nomex庐 generar谩 oportunidades de innovaci贸n y expansi贸n de mercado.
Arclin鞚赌 DuPont(NYSE:DD)鞚� 鞎勲澕氙鸽摐 靷梾攵�毳� 靸侅鞝侅澑 敫岆灉霌滌澑 Kevlar庐 氚� Nomex庐毳� 韽暔頃� 齑� 18鞏� 雼煬鞐� 鞚胳垬頃橁赴搿� 斓滌 瓿勳暯鞚� 觳搓舶頄堨姷雼堧嫟. 鞚� 瓯半灅電� 2026雲� 1攵勱赴 膦呺臧� 鞓堨儊霅橂┌ 頃车鞖办＜, 鞝勲牓 鞚疙攧霛�, 鞝勱赴彀�, 臧滌澑 氤错樃 鞛ル箘 氚� 甑癌 攵勳暭搿� Arclin鞚� 韽姼韽措Μ鞓るゼ 韥矊 頇曥灔頃� 瓴冹瀰雼堧嫟.
鞚措矆 鞚胳垬鞐愲姅 鞎� 1,900氇呾潣 歆侅洂鞚� 韽暔霅橂┌ Arclin鞚� 旮�搿滊矊 鞁滌灔 鞛呾毳� 臧曧檾頃� 瓴冹瀰雼堧嫟. 瓯挫劋 氚� 鞚疙攧霛� 攵勳暭鞐愳劀鞚� Arclin 鞝勲靹标臣 Kevlar庐路Nomex庐鞚� 瓴�歃濍悳 氤错樃 旮办垹鞚� 瓴绊暕霅橃柎 順侅嫚瓿� 鞁滌灔 頇曤寑鞚� 旮绊殞毳� 彀届稖頃� 瓴冹溂搿� 旮半寑霅╇媹雼�.
Arclin a conclu un accord d茅finitif pour acqu茅rir l'activit茅 aramides de DuPont (NYSE:DD), comprenant les embl茅matiques marques Kevlar庐 et Nomex庐, pour 1,8 milliard de dollars. La transaction, dont la cl么ture est pr茅vue au premier trimestre 2026, permettra d'茅tendre significativement le portefeuille d'Arclin aux secteurs a茅rospatial, infrastructures 茅lectriques, v茅hicules 茅lectriques, protection individuelle et d茅fense.
L'acquisition inclut environ 1 900 employ茅s et renforcera la pr茅sence mondiale d'Arclin. L'association de l'expertise d'Arclin dans la construction et les infrastructures avec les technologies de protection 茅prouv茅es de Kevlar庐 et Nomex庐 ouvrira des opportunit茅s d'innovation et d'expansion sur le march茅.
Arclin hat eine endg眉ltige Vereinbarung zum Erwerb des Aramid-Gesch盲fts von DuPont (NYSE:DD) geschlossen, einschlie脽lich der bekannten Marken Kevlar庐 und Nomex庐, f眉r 1,8 Milliarden US-Dollar. Der Abschluss der Transaktion wird f眉r das erste Quartal 2026 erwartet und wird Arclins Portfolio in den Bereichen Luft- und Raumfahrt, elektrische Infrastruktur, Elektrofahrzeuge, pers枚nliche Schutzausr眉stung und Verteidigung deutlich erweitern.
Die 脺bernahme umfasst rund 1.900 Mitarbeitende und wird Arclins globale Marktpr盲senz st盲rken. Die Verbindung von Arclins bestehender Expertise in Bau und Infrastruktur mit den bew盲hrten Schutztechnologien von Kevlar庐 und Nomex庐 schafft Chancen f眉r Innovation und Markterweiterung.
- Strategic acquisition of iconic Kevlar庐 and Nomex庐 brands for $1.8 billion expands portfolio into high-value sectors
- Addition of 1,900 experienced employees brings significant technical expertise
- Geographic expansion and entry into new markets including aerospace, defense, and electric vehicles
- Integration of proven protective technologies with existing product lines creates innovation opportunities
- Significant capital outlay of $1.8 billion may impact financial flexibility
- Integration risks with 1,900 new employees and complex product lines
- Regulatory approval requirements could delay closing until Q1 2026
Insights
DuPont's $1.8B sale of its Aramids business (Kevlar/Nomex) to Arclin represents a significant portfolio reshaping for DuPont and expansion opportunity for Arclin.
DuPont has entered into a definitive agreement to sell its Aramids business, including the iconic Kevlar庐 and Nomex庐 brands, to Arclin for
The transaction value of
For DuPont shareholders, this deal generates significant cash proceeds that could be deployed toward debt reduction, share repurchases, or strategic acquisitions in higher-growth segments. The company has been actively reshaping its portfolio in recent years to enhance shareholder returns and operational focus.
The transaction is expected to close in Q1 2026, subject to regulatory approvals, which shouldn't face significant hurdles given the distinct market segments and limited overlap between the companies. Arclin, backed by private equity firm TJC, L.P., gains globally recognized brands with established market positions in high-performance materials used in aerospace, electrical infrastructure, electric vehicles, personal protection, and defense sectors.
This move resembles similar divestiture strategies employed by other chemical conglomerates seeking to optimize their business mix, focus on higher-growth segments, and unlock shareholder value through streamlined operations.
Acquired brands to broaden and complement Arclin's innovation platform
"The Kevlar庐 and Nomex庐 brands have long been known for their innovation and protective qualities," said Bradley Bolduc, President and Chief Executive Officer of Arclin. "With this planned acquisition, Arclin will unlock the potential for these brands, ushering in a new era of advanced materials that can make homes, workplaces and communities stronger, safer and more resilient."
"DuPont is proud of the legacy of the Kevlar庐 and Nomex庐 brands," said Lori Koch, Chief Executive Officer of DuPont. "We are confident that under Arclin's leadership, these businesses will continue to thrive and expand their impact in new industries and applications."
"The global footprint of the Kevlar庐 and Nomex庐 businesses presents a unique opportunity for Arclin to expand into new markets both geographically and through new products and technologies," said Mark Glaspey, Chief Operating Officer of Arclin. "We are focused on unlocking opportunities across facilities, partners, and markets."
"We are thrilled to add these iconic and trusted brands to the Arclin portfolio," said Jana Wright, Arclin's Vice President of Brand & Marketing. "The Kevlar庐 and Nomex庐 brands align with our commitment to transform protective technologies, and we are excited about the potential to further innovate and serve a broader audience with these brands."
Transaction Highlights:
- Arclin has entered into an agreement to acquire DuPont's Aramids business, including the Kevlar庐 and Nomex庐 brands.
- Expands Arclin's portfolio with proven protective technologies trusted in personal and first responder safety.
- Enables Arclin to leverage the highly innovative products and technologies of Kevlar庐, Nomex庐 and Arclin.
- Positions Arclin to create technologies and develop new products that set industry standards.
- The acquisition includes approximately 1,900 employees who will bring decades of technical experience to Arclin.
- Strengthens Arclin's global market presence and accelerates entry into new geographies.
- Transaction expected to close in Q1 2026, subject to customary closing conditions and regulatory approvals.
Piper Sandler & Company is serving as financial advisor and Kirkland & Ellis LLP is serving as legal counsel to Arclin and TJC. Centerview Partners and Goldman Sachs & Co. LLC and are serving as DuPont's financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel.
About Arclin:
Arclin is a leading materials science company and manufacturer of polymer technologies, engineered products and specialized materials for the construction, agriculture, transportation infrastructure, weather & fire protection, pharmaceutical, nutrition, electronics, design, and other industries. Headquartered in
About TJC:
TJC, L.P., formerly known as The Jordan Company, has worked for more than 40 years with CEOs, founders and entrepreneurs across a range of industries including Diversified Industrials, Industrial Technology, Consumer & Healthcare,聽Logistics & Supply Chain and Technology & Infrastructure. With
About DuPont:
顿耻笔辞苍迟鈩⒙�(狈驰厂贰: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at . Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
DuPontTM and all products, unless otherwise noted, denoted with TM, SM or 庐 are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.
View original content to download multimedia:
SOURCE Arclin
FAQ
What is the value of Arclin's acquisition of DuPont's Aramids business?
When is the DuPont Aramids business acquisition expected to close?
How many employees will join Arclin from DuPont's Aramids business?
What new markets will Arclin enter with the Kevlar and Nomex acquisition?
Who are the financial advisors for the Arclin-DuPont Aramids deal?
